My research applies molecular biology to develop and screen highly diverse polymer libraries with the goal of developing new diagnostic, prognostic, and therapeutic agents for urologic oncology, particularly prostate cancer. We have used these techniques to develop RNA aptamers, peptides, and adenoviral gene therapy vectors to prostate cancer cell surface antigens. These agents are being used to target viruses, nanoparticles, imaging agents, and siRNA to prostate cancer cells expressing PSMA. My research interests also include urologic tissue specificity, for example, determining what qualities are specific to prostate cells and how can these be applied to generate new experimental diagnostic and therapeutic agents for prostate cancer.